Press Release Hub logo
  • Submit a Release
  • Home
  • All
  • ESG
  • Health
  • Technology
  • Finance
  • Contributors

Health

Results: 1765-1776 of 8145

PR Newswire associated0

Bayer Foundation Backs 15 Women Entrepreneurs Scaling Urgent Healthcare and Food Solutions

Business Wire logo

Varian Announces CE Mark for Embozene in Genicular Artery Embolisation, Expanding Treatment for Knee Osteoarthritis

PR Newswire associated0

Appointment of Silvère Lucquin as Chief Executive Officer of Okomera

PR Newswire associated0

Elevating Healthcare Innovation: ICP DAS-BMP Brings Advanced TPU Portfolio at Medtec China 2025

Business Wire logo

GekkoVet and Royal Canin Take Veterinary Decision Support Global After 92% Pilot Success

PR Newswire associated0

Sirtex Receives Expanded CE Mark Approval for SIR-Spheres® Y-90 Resin Microspheres

Queen Latifah Named Spokeswoman as WeightWatchers Launches First Comprehensive Menopause Programme

PR Newswire associated0

Klotho Neurosciences CEO to Attend Inaugural Conference & Scientific Seminar

PR Newswire associated0

AMO Pharma Enters into License Agreement with Population Health Research Institute (PHRI) and Venca Research Inc. to Advance Largest-Ever Study in Treatment of Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC)

Business Wire logo

KBI Biopharma, Inc. Announces Collaboration with Infinimmune Inc. to Support Antibody Manufacturing

PR Newswire associated0

FDA Accepts Letter of Intent to Qualify LSM by VCTE (FibroScan®) as First Non-Invasive Surrogate Endpoint in MASH Clinical Trials

PR Newswire associated0

Servier acquires potential treatment for Fragile X syndrome, the most common genetic cause of autism spectrum disorder

  • Prev Page
  • 1
  • 2
  • …
  • 147
  • 148
  • 149
  • …
  • 678
  • 679
  • Next Page

Pages

  • Home
  • All
  • ESG
  • Health
  • Technology
  • Finance
  • Contributors

Press Release Hub

  • Our Services
  • Submit a Release

Websites

  • PA Media Group
  • PA Mediapoint
  • Distribution Packages

© PA Media Group. 2026

Terms of Use

Privacy Policy

Contact Us